Brain Battle: Altman vs. Musk’s $1T Race to Control Human Consciousness | 2025 Analysis

25 Aug, 2025
| Salome K

The Brain Battle: Altman vs. Musk for control of the human brain

In a San Francisco laboratory, a paralyzed patient moves a computer cursor using only his thoughts. Thousands of miles away, in a research facility, scientists are developing technology that can control brain cells with ultrasound. Two visions of the same revolution: the direct connection between brain and computer.

Behind these breakthroughs are two men who were once partners, now fierce rivals: Sam Altman and Elon Musk. Their battle over the future of brain-computer interfaces (BCIs) began as a business disagreement but has evolved into a fundamental debate about how humans should relate to artificial intelligence.

By our International Platform editorial team – August, 2025

What began as a Silicon Valley partnership has escalated into a battle for the future of humanity. In 2015, Sam Altman and Elon Musk co-founded OpenAI, a nonprofit organization dedicated to developing safe and accessible artificial intelligence. However, the partnership quickly foundered. In 2018, Musk resigned from the board after his proposal to take control of OpenAI was roundly rejected. He has since accused OpenAI of betraying its original mission, particularly through its close collaboration with Microsoft.

In 2025, the feud reached a new peak when Musk made a hostile takeover bid of $97.4 billion for OpenAI. Altman called this offer “insultingly low.” This marked the end of the conflict, and the rivalry shifted to a new battlefield: the direct connection between human brain and computer.

Neuralink and the leap to disruptive implants

With Neuralink, Elon Musk focused on brain implants that record neuronal signals via ultrathin electrodes and translate them into digital commands. The initial results are concrete: since the FDA approved human trials in 2023, three paralyzed patients have been successfully implanted. They can control computers, type text, and even play games with their minds.

Neuralink announced plans to perform twenty to thirty new implants this year and is working on international expansion. While medical applications are currently focused on conditions like ALS and spinal cord injuries, Musk emphasizes that the ultimate goal is much broader. In his view, Neuralink is a necessary step toward enabling humans to compete with artificial intelligence.

The advantages are clear: high resolution and proven medical benefits. However, there are risks. These are invasive surgeries, where infection or rejection cannot be ruled out. Moreover, it remains uncertain how long the implants will continue to function reliably.

Merge Labs and the search for a biological alternative

Sam Altman is taking a radically different approach with Merge Labs. The startup combines gene therapy with ultrasound technology, modifying brain cells to send and receive signals via ultrasound waves. This method is less invasive and could theoretically target many more neurons simultaneously, increasing communication bandwidth.

The advantages are obvious: a less invasive procedure, more accessible to a wider audience, and potentially suitable for large-scale cognitive augmentation. But the risks are at least as great. Gene therapy remains experimental and raises questions about safety, long-term effects, and precision. The technology is still in its infancy, but the promise is immense.

From medical breakthrough to social revolution

The battle between Neuralink and Merge Labs transcends the technological dimension. Brain-computer interfaces (BCIs) have the potential to fundamentally change how people function. What are now medical devices could evolve into tools for cognitive enhancement, direct communication with AI, and even commercial applications.

This raises fundamental questions. Who controls the data extracted directly from the human brain? Will everyone have access to this technology, or will a neuro-elite emerge that thinks faster, remembers more, and is directly connected to artificial intelligence? Several countries are preparing legislation to protect neural rights. Chile became the first country to incorporate such “neurorights” into its constitution in 2021. Europe is following suit with debates on privacy and ethics, while the US and China dominate the technological race.

Geopolitics and militarization

The brain interface is not only a commercial market but also a geopolitical battleground. The US is leading the way with companies like Neuralink and Merge Labs, while China is investing heavily in non-invasive technology with military applications. Defense reports point to experiments in which soldiers use brain signals to react faster in combat situations.

For defense experts, the scenario of neuro-enhanced soldiers is more than science fiction. A pilot who can control a drone with his mind would be faster and more effective than someone who relies on conventional controllers. It opens the door to a militarization of brain technology that could transform the warfare of the future.

The commercial battle for a trillion-dollar market

Investors see a market in brain interfaces that could become as large as smartphones or the internet. The global BCI market is estimated to grow from $2.1 billion in 2022 to over $20 billion in 2030. Optimistic analysts even predict a potential trillion-dollar industry by 2040, once cognitive augmentation becomes widely available.

Major tech companies are already joining the fray. Microsoft, through its partnership with OpenAI and Merge Labs, sees opportunities for integration with productivity tools. Google and Apple are working behind the scenes on neurotechnologies that can be linked to augmented and virtual reality. For these companies, not only profit is at stake, but also control over the most personal data in existence: human thoughts and emotions.

A battle for the definition of being human

The battle between Musk and Altman is therefore more than a technological race. It’s a battle over how humans will function in the 21st century. Will brain interfaces be used as medical devices and tools of emancipation? Or will they be the next step in a world dominated by inequality, control, and data exploitation?

The choices made today will determine whether brain-computer interfaces prove to be a blessing or a curse. Musk and Altman embody two different visions: the disruptive hardware approach versus the biologically inspired caution. Both are convinced that the brain holds the key to the future. For the rest of humanity, the question remains whether that future will be liberating, controlling, or even frightening.

The battle for the human future

The battle between Altman and Musk goes beyond technology or business success. It’s a battle over the definition of humanity in the 21st century. Hardware versus biology, disruption versus integration, speed versus security.

What is certain is that the brain has become the new battleground for innovation. Whether brain-computer interfaces lead to healing, augmentation, or control will determine whether this technology proves to be a blessing or a curse.

The winner of this battle will determine not only a market, but potentially the cognitive infrastructure of the future. In this sense, Altman and Musk aren’t just fighting each other—they’re fighting over nothing less than the evolution of human consciousness itself.